Progress in Cardiovascular Diseases Profile
Progress in Cardiovascular Diseases

@PCVDJournal

Followers
227
Following
26
Media
102
Statuses
157

Official account for Progress in Cardiovascular Diseases Journal. Impact Factor 7.6 #22/230 CV Journals. @ElsevierConnect

Joined January 2025
Don't wanna be here? Send us removal request.
@PCVDJournal
Progress in Cardiovascular Diseases
5 days
Check out the editorial by @nstonedoc - Reducing the burden of ischemic stroke with lipid expertise https://t.co/BZ4g02WrZI Consensus statement led by @maciejbanach https://t.co/G1L0KXqueq
0
2
3
@PCVDJournal
Progress in Cardiovascular Diseases
5 days
๐Ÿ†•๐Ÿ“ The prognostic value of N-terminal pro-B-type natriuretic peptide in patients with severe aortic stenosis and preserved ejection fraction ๐Ÿ”— https://t.co/if3d63vqCV @AkivaRosenzveig @tavrkapadia @Sciencedirect @ElsevierConnect #Cardiology #CardioTwitter #CardioEd
0
3
8
@PCVDJournal
Progress in Cardiovascular Diseases
6 days
Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis https://t.co/Gklb5eSCKa @drleonmartin
0
2
2
@PCVDJournal
Progress in Cardiovascular Diseases
14 days
Myosin inhibition in obstructive HCM: A new starting point for therapy @dr_pavia https://t.co/c9bQ6gytDK
0
1
2
@PCVDJournal
Progress in Cardiovascular Diseases
14 days
Medicolegal implications and litigation trends in the diagnosis and management of cardiomyopathies in the United States https://t.co/qM76rFDce4 @MasriAhmadMD
1
1
5
@PCVDJournal
Progress in Cardiovascular Diseases
22 days
๐Ÿ†•โœ๏ธEditorial โžก๏ธA simple test, a profound signal: Handgrip asymmetry and the risk of death ๐Ÿ”— https://t.co/To3tnFf2RV @LaukkanenJari Original manuscript ๐Ÿ”— https://t.co/gQsNyF5rL2 @jcalatayud_ @ElsevierConnect @sciencedirect #cardiotwitter #Cardiology #CardioEd
0
1
0
@PCVDJournal
Progress in Cardiovascular Diseases
28 days
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP) https://t.co/G1L0KXqueq @maciejbanach
0
1
3
@PCVDJournal
Progress in Cardiovascular Diseases
1 month
๐Ÿ†•๐Ÿ“ Multimodality imaging approaches for diagnosis of cardiac amyloidosis ๐Ÿ”— https://t.co/fPALRd9MUP @DrRojulpoteC @DorbalaSharmila @sarahcud @sciencedirect @ElsevierConnect #Cardiology #cardiotwitter #CardioEd #CardioX #HFpEF
0
3
9
@PCVDJournal
Progress in Cardiovascular Diseases
1 month
Timing of transcatheter aortic valve replacement after balloon aortic valvuloplasty: Insights from a multicenter real-world cohort @tavrkapadia @ClevelandClinic https://t.co/R08uqIKypM
0
5
16
@PCVDJournal
Progress in Cardiovascular Diseases
1 month
0
0
1
@PCVDJournal
Progress in Cardiovascular Diseases
1 month
New editorial by @PPibarot "Outcomes of TAVR in severe aortic stenosis: Very low gradient is not necessarily good news" https://t.co/5GnM3l6HG8
@PCVDJournal
Progress in Cardiovascular Diseases
3 months
Clinical outcomes following TAVR for patients with low and very low gradient aortic stenosis @tavrkapadia @ClevelandClinic https://t.co/5GnM3l7fvG
1
0
2
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ†•Review๐Ÿ“š Silence is not always Golden: Should we perform catheter ablation in asymptomatic atrial fibrillation? Clinical debate and emerging evidence ๐Ÿ”— https://t.co/IPUKNYfk6U @marcoschiavone5 @LuigiDiBiaseMD @sciencedirect @ElsevierConnect #Cardiology #cardiotwitter
0
2
5
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ†•โœ๏ธ Editorial โžก๏ธThe colchicineโ€“sodium-glucose cotransporter two inhibitors conundrum: Promise, pitfalls, and next steps ๐Ÿ”— https://t.co/rzjZ2ful7m @AliBAbdulJabbar @virani_md @AsmaAhmedHassan Original article ๐Ÿ”— https://t.co/c8OkQvKfy4 #Cardiology #cardiotwitter #CardioEd
0
1
5
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ†•โœ๏ธEfficacy and safety of cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy: Systematic review and comprehensive frequentist and Bayesian meta-analyses of Phase 3 randomized controlled trials ๐Ÿ”— https://t.co/sze4uMyIfq @matthewmylee @carolinecoats
0
4
8
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ†•Quantification of myocardial blood flow using PET: Current status, clinical applications, and future directions ๐Ÿ”— https://t.co/D6zvJW4zuc @docvikrama @sciencedirect @ElsevierConnect #ThinkPET #Cardiology #cardiotwitter #CardioEd
0
2
4
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ”—
0
0
0
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ”—
0
0
0
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ”—
0
0
0
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ†• Handgrip strength asymmetry increases risk of all-cause and cardiovascular mortality: A dose-response analysis across 28 countries ๐Ÿ”— https://t.co/wrtMXfi829 @LarsLAndersen @jcalatayud_ @ElsevierConnect @sciencedirect #Cardiology #cardiotwitter #CardioEd
0
0
0
@PCVDJournal
Progress in Cardiovascular Diseases
2 months
๐Ÿ†•๐Ÿ“œ Artificial intelligence in nuclear cardiology: Enhancing diagnostic accuracy and efficiency @robertjhmiller @Piotr_JSlomka @PanithayaC @ElsevierConnect @sciencedirect #ThinkPET #Cardiology #cardiotwitter #CardioEd
1
2
5